| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $183.5M | +4.0% | +15.2% |
| Cost of Revenue | $44.0M | +0.4% | +22.1% |
| Gross Profit | $139.5M | +5.1% | +13.2% |
| R&D Expense | $38.6M | -1.5% | +7.3% |
| SG&A Expense | $35.0M | -2.4% | -3.1% |
| Operating Income | -$3.4M | +77.2% | +78.5% |
| Pre-tax Income | -$6.4M | +63.1% | +41.8% |
| Income Tax | -$1.8M | -151.1% | -241.1% |
| Net Income | -$4.5M | +78.4% | +63.1% |
| EPS (Basic) | -$0.03 | +81.3% | +70.0% |
| EPS (Diluted) | -$0.03 | +81.3% | +70.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $547.2M | +13.6% | +150.5% |
| Accounts Receivable | $154.7M | +2.9% | +35.7% |
| Current Assets | $777.2M | +10.7% | +94.9% |
| Total Assets | $2.14B | +2.4% | +35.0% |
| Current Liabilities | $893.8M | +85.1% | +113.3% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $107.4M | — | — |
| Capital Expenditures | $4.6M | — | — |
| Investing Cash Flow | -$183.1M | — | — |
| Financing Cash Flow | $395.3M | — | — |
| Free Cash Flow | $102.9M | — | — |
| $1.35B |
| +2.9% |
| +56.6% |
| Stockholders' Equity | $786.7M | +1.5% | +9.2% |